Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development

MRM Health rewarded a €2.6M VLAIO Research Grant to accelerate the development of novel therapeutics that redefine the treatment of immunemediated inflammatory diseases

Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium

UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell engagers

Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate

Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline

Afrigen Biologics Announces RSV mRNA Vaccine Collaboration with RespIP BV

Healthbridgers and Schuttelaar & Partners Join Forces to Advance Sustainable Healthcare Pathways

Greywolf Therapeutics appoints Edwin Moses as Chair